ABGSC Life Science Summit

Patient insights to shape development of a dCBT for IPF patients

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

C21 shows promise against COVID-19 where other drugs have failed

Top line data on the ATTRACT study